CL2013001313A1 - Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales - Google Patents

Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales

Info

Publication number
CL2013001313A1
CL2013001313A1 CL2013001313A CL2013001313A CL2013001313A1 CL 2013001313 A1 CL2013001313 A1 CL 2013001313A1 CL 2013001313 A CL2013001313 A CL 2013001313A CL 2013001313 A CL2013001313 A CL 2013001313A CL 2013001313 A1 CL2013001313 A1 CL 2013001313A1
Authority
CL
Chile
Prior art keywords
composition
prevent
probiotic microorganisms
gastrointestinal infections
treat gastrointestinal
Prior art date
Application number
CL2013001313A
Other languages
English (en)
Inventor
Annick Mercenier
Sophie Nutten
Valerie Petit
Clara Lucia Garcia-Rodenas
Monique Julita
Guenolee Prioult
Original Assignee
Nestes S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43618887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013001313(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestes S A filed Critical Nestes S A
Publication of CL2013001313A1 publication Critical patent/CL2013001313A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CL2013001313A 2010-11-11 2013-05-10 Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales CL2013001313A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10190847A EP2455094A1 (en) 2010-11-11 2010-11-11 Non-replicating probiotic micro-organisms protect children against gastrointestinal infections

Publications (1)

Publication Number Publication Date
CL2013001313A1 true CL2013001313A1 (es) 2014-03-07

Family

ID=43618887

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013001313A CL2013001313A1 (es) 2010-11-11 2013-05-10 Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales

Country Status (16)

Country Link
US (1) US9345728B2 (es)
EP (2) EP2455094A1 (es)
CN (1) CN103282040A (es)
AU (1) AU2011328137A1 (es)
BR (1) BR112013011759A2 (es)
CA (1) CA2817407A1 (es)
CL (1) CL2013001313A1 (es)
ES (1) ES2542956T3 (es)
IL (1) IL226210A0 (es)
MX (1) MX336125B (es)
PL (1) PL2637677T3 (es)
PT (1) PT2637677E (es)
RU (1) RU2568830C2 (es)
SG (1) SG190170A1 (es)
WO (1) WO2012062781A1 (es)
ZA (1) ZA201304245B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY171851A (en) 2011-06-20 2019-11-04 Heinz Co Brands H J Llc Probiotic compositions and methods
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
ES2883552T3 (es) 2012-06-18 2021-12-09 Heinz Co Brands H J Llc Trastornos relacionados con el gluten
US9987316B2 (en) 2012-09-14 2018-06-05 Case Western Reserve University Probiotic controlling fungi and uses thereof
PL3470074T3 (pl) 2013-05-10 2021-04-06 H.J. Heinz Company Brands Llc Probiotyki
CN110964665B (zh) * 2019-12-20 2020-09-25 哈尔滨美华生物技术股份有限公司 一种用于胃切除术后治疗的益生菌组合物及其制备方法
CN118308273B (zh) * 2024-06-07 2024-08-09 山东中科嘉亿生物工程有限公司 一种能够抵抗抗生素、改善便秘的益生菌剂及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2102485T3 (es) 1992-07-06 1997-08-01 Nestle Sa Bacteria lactica.
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
CN1186440C (zh) 1999-08-05 2005-01-26 雀巢制品公司 预防病原性细菌引起的腹泻的新双歧杆菌
PT1353681E (pt) 1999-08-05 2008-02-25 Nestle Sa ''bifidobactérias capazes de evitar a diarreia''
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
CA2559813A1 (en) 2004-03-16 2005-09-22 Combi Co. Antidiarrheal agent for livestock and poultry
KR101155735B1 (ko) * 2004-03-31 2012-06-12 가부시키가이샤 메이지 항균성 조성물
US7648270B2 (en) * 2004-04-02 2010-01-19 Avago Technologies General Ip (Singapore) Pte. Ltd. Temperature measurement of an integrated circuit
US7603432B2 (en) * 2005-06-06 2009-10-13 Aa, Llc Locality based alert method and apparatus
WO2008106373A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Product containing inactivated probiotic for children or infants
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US9113641B2 (en) * 2007-12-06 2015-08-25 Arla Foods Amba Probiotic bacteria and regulation of fat storage
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
EP2251020A1 (en) 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
WO2010130662A1 (en) 2009-05-11 2010-11-18 Nestec S.A. LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
EP2449889A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Rice pudding preparations containing probiotic micro-organisms
ES2565407T3 (es) * 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children

Also Published As

Publication number Publication date
EP2455094A1 (en) 2012-05-23
CN103282040A (zh) 2013-09-04
RU2568830C2 (ru) 2015-11-20
RU2013126602A (ru) 2014-12-20
ZA201304245B (en) 2016-02-24
PT2637677E (pt) 2015-09-11
EP2637677A1 (en) 2013-09-18
MX336125B (es) 2016-01-07
SG190170A1 (en) 2013-06-28
CA2817407A1 (en) 2012-05-18
ES2542956T3 (es) 2015-08-13
BR112013011759A2 (pt) 2016-09-13
US9345728B2 (en) 2016-05-24
IL226210A0 (en) 2013-07-31
MX2013005370A (es) 2013-06-28
PL2637677T3 (pl) 2015-11-30
US20130224254A1 (en) 2013-08-29
EP2637677B1 (en) 2015-06-17
WO2012062781A1 (en) 2012-05-18
AU2011328137A1 (en) 2013-05-30

Similar Documents

Publication Publication Date Title
BR112013011881A2 (pt) micro-organismos probióticos não replicantes que protegem contra infecções do trato respiratório superior
CL2013001134A1 (es) Composicion de yogurt congelado que comprende microorganismos probioticos no replicantes .
CL2012000487A1 (es) Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales.
CO6801729A2 (es) Composiciones y métodos para modular el fxr
BR112013012598A2 (pt) composição de oligossacarídeos para tratar infecções agudas do trato respiratório
CL2013001313A1 (es) Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales
BR112012031667A2 (pt) composição
ES2898695T8 (es) Derivados de benzoxaborol para el tratamiento de infecciones bacterianas
BR112012031855A2 (pt) composição e artigo
BR112012032683A2 (pt) composição
BR112012027165A2 (pt) composição e artigo
CL2014002348A1 (es) Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado.
CO6801724A2 (es) Composiciones y métodos para el tratamiento de la mielofibrosis
CL2013001315A1 (es) Composicion que comprende micro-organismo probioticos no replicantes extruidos.
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
BR112012032980A2 (pt) composição
BR112013016223A2 (pt) películas e composições compreendendo as mesmas
CL2013001314A1 (es) Composicion de yogur de consistencia espesa que comprende microorganismos probióticos no replicantes.
PT2575971E (pt) Extratos combinados de plantas para utilização no tratamento de infeções microbianas
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
ITTO20110268A1 (it) Composizione di maquillage.
BR112012019786A2 (pt) processo para prevenir ou atenuar bioincrustação
BR112013015048A2 (pt) composição para o tratamento de distúrbios metabólicos
BRPI0921730A2 (pt) Compisição para ativar e/ou estabilizar micro-organismos
BR112013007039A2 (pt) "composição de tratamento pessoal"